CTI BioPharma Corp. Profile Avatar - Palmy Investing

CTI BioPharma Corp.

CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhi…

Biotechnology
US, Seattle [HQ]
Strategy & Leadership

Officers & BofD Beta

  • Form 3/4/5
  • Proxy DEF-14A

Total Compensation

- No data, only available if we have DEF 14A compensations in place -
Officers
Name & Position Research Last Appearance
- No data available -
Board of Directors (BofD)
Name & Position Research Last Appearance
- No data available -
End of CTIC's Analysis
CIK: 891293 CUSIP: 12648L601 ISIN: US12648L6011 LEI: - UEI: -
Secondary Listings
CTIC has no secondary listings inside our databases.